Menu
Back to User profile » Dr Klaus Rabe
Papers published by Dr Klaus Rabe:
Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE2SPOND rationale and study design
Rennard SI, Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Siddiqui S, Anzueto A, Zhu H
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1921-1928
Published Date: 17 August 2016
Exacerbations of COPD
Pavord ID, Jones PW, Burgel PR, Rabe KF
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:21-30
Published Date: 19 February 2016
Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease
Miravitlles M, Price D, Rabe KF, Schmidt H, Metzdorf N, Celli B
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:549-564
Published Date: 16 March 2015
Anti-inflammatory effects of budesonide in human lung fibroblasts are independent of histone deacetylase 2
Wang X, Nelson A, Weiler ZM, Patil A, Sato T, Kanaji N, Nakanishi M, Michalski J, Farid M, Basma H, LeVan TD, Miller-Larsson A, Wieslander E, Muller KC, Holz O, Magnussen H, Rabe KF, Liu X, Rennard SI
Journal of Inflammation Research 2013, 6:109-119
Published Date: 20 August 2013
Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol
Calverley PM, Martinez FJ, Fabbri LM, Goehring UM, Rabe KF
International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:375-382
Published Date: 20 June 2012